Charlotte's Web (CWBHF) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
28 May, 2026Opening remarks and agenda
Meeting commenced virtually with introductions of board members and senior officers present.
Voting procedures and meeting protocols were outlined, including use of the virtual platform and proxy voting.
Board and executive committee updates
Board size fixed at six directors for the ensuing year, with nominations and elections conducted.
Six directors were nominated and elected to serve until the next AGM or until successors are appointed.
Appointment of PKF O'Connor Davies, LLP as auditor was approved, with remuneration to be fixed by the board.
Shareholder proposals
Approval sought and obtained for amendment of a CAD 75.3M convertible debenture held by BT DE Investments (British American Tobacco subsidiary), including issuance of common shares and a concurrent equity investment.
Transaction results in a new controlled person and issuance of over 25% of outstanding shares.
Latest events from Charlotte's Web
- Q2 2026 saw revenue drop, margin expand, and a major equity conversion strengthen the balance sheet.CWBHF
Q2 2026 - Market-leading CBD innovator, recapitalized for growth and positioned for regulatory-driven expansion.CWBHF
Investor presentation - Q1 2026 revenue dropped 9% and net loss widened, with a major BAT debt deal pending approval.CWBHF
Q1 2026 - Returned to growth as the #1 CBD brand, leveraging innovation, partnerships, and regulatory momentum.CWBHF
Investor presentation - Shareholders to vote on BAT transaction, director elections, and key governance matters.CWBHF
Proxy filing - Key votes include director elections and a debenture amendment that may shift company control.CWBHF
Proxy filing - Shareholders to vote on BAT's conversion to a control person, reshaping ownership and governance.CWBHF
Proxy filing - Transformed balance sheet, renewed growth, and Medicare pilot position drive future upside.CWBHF
Q4 2025 - Sequential revenue growth and cost cuts signal a turnaround amid regulatory challenges.CWBHF
Q2 2024